HCPCS J-Codes
Drugs administered other than oral method, chemotherapy drugs

These codes are used to report injectable drugs that ordinarily cannot be self-administered; chemotherapy, immunosuppressive drugs and inhalation solutions as well as some orally administered drugs.


View All HCPCS Sections
  • J0893

    Injection, decitabine (sun pharma), not therapeutically equivalent to j0894, 1 mg
  • J0894

    Injection, decitabine, 1 mg
  • J0895

    Injection, deferoxamine mesylate, 500 mg
  • J0896

    Injection, luspatercept-aamt, 0.25 mg
  • J0897

    Injection, denosumab, 1 mg
  • J0898

    Injection, argatroban (auromedics), not therapeutically equivalent to j0883, 1 mg (for non-esrd use)
  • J0899

    Injection, argatroban (auromedics), not therapeutically equivalent to j0884, 1 mg (for esrd on dialysis)
  • J0900

    Injection, testosterone enanthate and estradiol valerate, up to 1 cc
  • J0901

    Vadadustat, oral, 1 mg (for esrd on dialysis)
  • J0911

    Instillation, taurolidine 1.35 mg and heparin sodium 100 units (central venous catheter lock for adult patients receiving chronic hemodialysis)
  • J0945

    Injection, brompheniramine maleate, per 10 mg
  • J1000

    Injection, depo-estradiol cypionate, up to 5 mg
  • J1010

    Injection, methylprednisolone acetate, 1 mg
  • J1020

    Injection, methylprednisolone acetate, 20 mg
  • J1030

    Injection, methylprednisolone acetate, 40 mg
  • J1040

    Injection, methylprednisolone acetate, 80 mg
  • J1050

    Injection, medroxyprogesterone acetate, 1 mg
  • J1060

    Injection, testosterone cypionate and estradiol cypionate, up to 1 ml
  • J1070

    Injection, testosterone cypionate, up to 100 mg
  • J1071

    Injection, testosterone cypionate, 1 mg
  • J1072

    Injection, testosterone cypionate (azmiro), 1 mg
  • J1073

    Testosterone pellet, implant, 75 mg
  • J1080

    Injection, testosterone cypionate, 1 cc, 200 mg
  • J1094

    Injection, dexamethasone acetate, 1 mg
  • J1095

    Injection, dexamethasone 9 percent, intraocular, 1 microgram
  • J1096

    Dexamethasone, lacrimal ophthalmic insert, 0.1 mg
  • J1097

    Phenylephrine 10.16 mg/ml and ketorolac 2.88 mg/ml ophthalmic irrigation solution, 1 ml
  • J1098

    Articaine ophthalmic, 8% solution, 0.4 ml
  • J1100

    Injection, dexamethasone sodium phosphate, 1 mg
  • J1105

    Dexmedetomidine, oral, 1 mcg
  • J1110

    Injection, dihydroergotamine mesylate, per 1 mg
  • J1120

    Injection, acetazolamide sodium, up to 500 mg
  • J1130

    Injection, diclofenac sodium, 0.5 mg
  • J1160

    Injection, digoxin, up to 0.5 mg
  • J1162

    Injection, digoxin immune fab (ovine), per vial
  • J1163

    Injection, diltiazem hydrochloride, 0.5 mg
  • J1164

    Injection, diltiazem hydrochloride in 0.72% sodium chloride, 0.5 mg
  • J1165

    Injection, phenytoin sodium, per 50 mg
  • J1170

    Injection, hydromorphone, up to 4 mg
  • J1171

    Injection, hydromorphone, 0.1 mg
  • J1180

    Injection, dyphylline, up to 500 mg
  • J1190

    Injection, dexrazoxane hydrochloride, per 250 mg
  • J1200

    Injection, diphenhydramine hcl, up to 50 mg
  • J1201

    Injection, cetirizine hydrochloride, 0.5 mg
  • J1202

    Miglustat, oral, 65 mg
  • J1203

    Injection, cipaglucosidase alfa-atga, 5 mg
  • J1205

    Injection, chlorothiazide sodium, per 500 mg
  • J1212

    Injection, dmso, dimethyl sulfoxide, 50%, 50 ml
  • J1230

    Injection, methadone hcl, up to 10 mg
  • J1240

    Injection, dimenhydrinate, up to 50 mg

HCPCS Level II codes and descriptors are approved and maintained jointly by the alpha-numeric editorial panel (consisting of CMS, the Health Insurance Association of America, and the Blue Cross and Blue Shield Association). — Updated 6/3/2026

CPT® is a registered trademark of the American Medical Association (AMA). All rights reserved.